Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 234 (RNA5SP234)

Target
RNA5SP234
Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

RNA, 5S ribosomal pseudogene 234 (RNA5SP234) is classified as a pseudogene related to the 5S ribosomal RNA gene family[1][2]. Pseudogenes like RNA5SP234 represent genomic DNA sequences similar to known genes, but typically lack the capacity to encode functional RNA or protein due to mutations or genetic alterations disrupting normal gene expression[1][2]. There is currently no evidence that RNA5SP234 is transcribed into a functional RNA, nor does it encode a protein or play a direct biological role. Unlike functional 5S ribosomal RNA, which folds into a conserved secondary structure and participates in the assembly and function of the ribosome[3][5], RNA5SP234 does not contribute to ribosomal assembly or function. It is not considered a therapeutic target, and there are no known drugs, biomarkers, disease associations, or established clinical relevance for this pseudogene[1][2]. The entry's relevance is primarily for genomic annotation and evolutionary studies of gene families rather than for disease, pharmacology, or biomarker applications. Notes: - RNA5SP234 is a processed pseudogene, meaning it originated from a reverse-transcribed RNA product inserted back into the genome, and not from gene duplication or rearrangement that retains function[1][2]. - While other pseudogenes can occasionally influence gene regulation or serve as disease biomarkers[4], there is no published evidence for any such role for RNA5SP234 specifically. - The entry may be considered "incorrect" in a therapeutic/biological targeting context because it is not a functional gene, receptor, or target, but rather a non-functional genomic sequence[1][2].

Other names
RN5S234RNA5SP234RNA, 5S ribosomal 234
02

Mechanism of action

None

03

Biological functions

None (pseudogene; presumed non-functional in terms of coding or regulatory roles)
04

Disease associations

None established
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 234 (RNA5SP234).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 234 (RNA5SP234).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call